FTH — Faeth Therapeutics, Share News
0.000.00%
Last trade - 00:00- $459.38m
- $256.60m
Brief: Sensei Biotherapeutics Appoints William Ringo, Mba, As Chair Of Board Of Directors
Brief: Sensei Biotherapeutics Announces Executive Promotions
Brief: Sensei Biotherapeutics Announces Addition To The Nasdaq Biotechnology Index
Brief: Sensei Biotherapeutics Presents Preclinical Data for SNS-101 at SITC 36th Annual Meeting
Brief: Sensei Biotherapeutics Reports Qtrly Net Loss Per Share Of $0.32
Brief: Sensei Biotherapeutics To Present New Data For SNS-101 At The Society For Immunotherapy Of Cancer
Sensei Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sensei Biotherapeutics Reports Second Quarter 2021 Results
Brief: Sensei Biotherapeutics Appoints Kristian Humer To Its Board
Brief: Sensei Biotherapeutics Announces Prioritization Of Next-Generation Multi-Antigenic Immunophage Platform
U.S. STOCKS ON THE MOVE-Virgin Galactic, Kohl's, Ralph Lauren, Tesla
Sensei Biotherapeutics: Jumps on new data from head-and-neck cancer drug study
Brief: Sensei Biotherapeutics Announces Clinical Data From Ongoing Phase 1/2 Combination Trial Of SNS-301 In Patients With Squamous Cell Carcinoma Of The Head And Neck
Sensei Biotherapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sensei Biotherapeutics Posts Qtrly Loss Per Share $0.42
Brief: Sensei Biotherapeutics Appoints Jessie M. English, Ph.D. To Its Board Of Directors
Brief: Sensei Biotherapeutics Reports Full Year 2020 Results
Sensei Biotherapeutics: Piper Sandler starts with "overweight" on immunotherapy platform potential
Sensei Biotherapeutics: Jumps 30% in Nasdaq debut